Financial information materials | Almirall
Dermatology
Conditions
- Atopic dermatitis
- Psoriasis
- Actinic keratosis
- Acne
- Other skin conditions
Financial Information Materials
An Accessible Source of Financial Insight
Find all the essential financial information materials that you might need in order to assess our performance and understand the context behind our results. We aim to present the information in a structured, practical way so that users can follow our progress throughout the year, form a clear perspective on our financial position, and keep abreast of the factors that shape our strategic direction.
Investors
Stock Information
- Share performance
- Share capital & ownership
- Share and capital structure
- Share issues
- Shareholdings
- Analyst coverage
- Corporate actions & financing
- Takeover bids
- Dividends
- Debt issues
- Financial data
- Public periodic information
- Financial information materials
- Financial data
- Factsheet
- Corporate presentations
- Average period of payment to suppliers
CNMV Communications
Significant Events
Inside Information
Corporate Governance
- Shareholders annual general meeting
- Board of directors
- Board commissions
- Corporate governance & directors’ remuneration reports
- Agreements between significant shareholders
- Corporate rules and policies
Corporate Responsibility
- Information security in Almirall
Our Leadership
Reports
Regular Financial Updates
We publish periodic materials that reflect our performance at key points in the year. These include quarterly reports, summaries of results, and detailed financial datasets that provide a clear breakdown of revenue, expenses, investments, and operational highlights. Our goal is to offer clarity through consistent, reliable reporting.
Presentations and Analyst Resources
To complement data-based materials, we also share presentations and resources designed for analysts, investors, and financial stakeholders. These documents summarize our strategic priorities, explain the context of our performance, and highlight indicators that support long-term forecasting.
Supporting Well-Informed Decisions
We consider transparency a fundamental part of our relationship with investors. We remain committed to openness, accuracy, and a consistent flow of relevant information.
Factsheet
Download a company overview including the current share performance, latest news, upcoming investor events, and key financial figures.
Corporate Presentations
Here, we provide corporate presentations submitted to the analyst and investors community.
- 44th Annual J.P. Morgan Healthcare Conference 2026 PDF 1.2MB
- Presentation of 16 weeks data for Lebrikizumab ADvocate 1 & 2 Phase 3 studies PDF 1.9MB
Average Period of Payment to Suppliers
Information on delays in payments to suppliers CCAA
Information on delays in payments to suppliers CCAACC